Fiduciary Trust CO Blueprint Medicines Corp Transaction History
Fiduciary Trust CO
- $7.36 Billion
- Q4 2024
A detailed history of Fiduciary Trust CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fiduciary Trust CO holds 10,152 shares of BPMC stock, worth $898,553. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,152
Previous 10,152
-0.0%
Holding current value
$898,553
Previous $938,000
5.65%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BPMC
# of Institutions
386Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$600 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$588 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$503 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$221 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$172 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.29B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...